Business Context and Reporting Period
Company: Philip Morris Companies Inc. (Note: Metadata listed Altria Group, Inc., but the filing text identifies Philip Morris Companies Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1996
Business Segments: Consumer Products (Tobacco, Food, Beer) and Financial Services & Real Estate.
Key Financial Metrics (Nine Months Ended Sept 30, 1996)
| Metric | 1996 ($ Millions) | 1995 ($ Millions) |
|---|---|---|
| Operating Revenues | $52,414 | $50,335 |
| Gross Profit | $21,181 | $20,047 |
| Operating Income | $9,014 | $8,106 |
| Net Earnings | $4,832 | $4,178 |
| Earnings Per Share (Diluted) | $5.87 | $4.95 |
| Cash from Operating Activities | $4,522 | $4,437 |
| Total Debt | $16,518 | $15,813 |
| Cash & Equivalents | $459 | $1,138 (Dec 31, 1995) |
Note: Total Debt calculated as Short-term borrowings ($541M) + Current portion of long-term debt ($1,755M) + Long-term debt ($14,233M).
Material Changes vs. Prior Period
- Revenue Growth: Operating revenues increased 4.1% ($2.1 billion) year-over-year, driven primarily by tobacco segment growth which offset declines in food revenues due to divestitures.
- Profitability: Operating income rose 11.2% ($908 million). Net earnings increased 14.9% ($626 million), aided by lower interest expense and share repurchases reducing the share count.
- Segment Performance:
- Tobacco: Domestic revenues up 8.8%; International revenues up 14.7%. Volume gains in both segments, with Marlboro gaining significant market share.
- Food: North American revenues down 10.1% due to divestitures; International revenues up 4.3%.
- Beer: Revenues flat (up 0.6%); volume declined 2.6% due to competition and weather.
- Cash Flow: Operating cash flow increased slightly ($85 million). Investing cash outflows surged to $1.6 billion (vs. $358 million used in 1995) due to acquisitions (ZPT-Krakow, Lacta). Financing cash outflows increased to $3.5 billion due to higher stock repurchases and dividends.
Guidance, Outlook, and Risks
- Regulatory Risks: The FDA issued final regulations asserting jurisdiction over nicotine as a "drug" and cigarettes as "medical devices." The Company is challenging this in court. Unfavorable outcomes could severely impact operations.
- Legal Contingencies: Over 240 smoking and health cases are pending in the U.S., including class actions and state Medicaid recovery suits (e.g., Florida, Mississippi). Management cannot estimate potential losses but believes outcomes will not materially affect financial position.
- Foreign Currency: Unfavorable currency movements (primarily Japanese Yen) reduced operating income by $109 million in the first nine months. Management expects this to continue impacting 1996 and 1997 results.
- Divestitures & Acquisitions: The Company continues to divest non-strategic food businesses while acquiring international tobacco and food assets (e.g., ZPT-Krakow, Lacta).
- Dividend: Quarterly dividend increased to $1.20 per share (20% increase), annualized to $4.80.
Investor Verification Checklist
- Legal Exposure: Monitor the status of the FDA regulatory challenge and the Florida Medicaid recovery trial scheduled for August 1997.
- Debt Structure: Verify the reclassification of $2.8 billion in short-term borrowings to long-term debt based on the $8 billion revolving credit facility.
- Foreign Operations: Assess the impact of the Italian tax investigation (alleged $104.5 million liability) and currency hedging effectiveness.
- Share Count: Confirm the impact of the $6 billion share repurchase program on future earnings per share.
- Food Segment: Track the completion of pending divestitures (e.g., Malaco) and the integration of new acquisitions.